Biosante Pharma (AMEX:BPA)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more Biosante Pharma Charts. Click Here for more Biosante Pharma Charts.](/p.php?pid=staticchart&s=A%5EBPA&p=8&t=15)
Rodman & Renshaw, LLC initiated research coverage of
BioSante Pharmaceuticals (AMEX: BPA) with a Market Outperform Rating
and a 12-month price target $7. Ilya Kravets, Senior Specialty
Pharmaceuticals Analyst, issued the report.
About Rodman & Renshaw, LLC
Rodman & Renshaw is a privately held, full-service investment bank
committed to fostering the long-term success of growth companies
through capital raising, strategic advice, insightful research, and
the development of institutional support. More information is
available at www.rodmanandrenshaw.com
None of the research analysts or the research analyst's household
has a financial interest in the securities of BioSante Pharmaceuticals
(including, without limitation, any option, right, warrant, future,
long or short position).
As of August 31, 2005, neither Rodman & Renshaw, LLC nor its
affiliates beneficially own 1% or more of any class of common equity
securities of BioSante Pharmaceuticals.
Neither the research analyst nor Rodman & Renshaw, LLC has any
material conflict of interest with BioSante Pharmaceuticals, of which
the research analyst knows or has reason to know at the time of
publication of this research report.
Rodman & Renshaw, LLC or its affiliates did not receive
compensation from BioSante Pharmaceuticals for investment banking
services within the last twelve months and Rodman & Renshaw, LLC
intends to seek compensation from BioSante Pharmaceuticals for
investment banking services within three months, following publication
of the research report.
Neither the research analyst nor any member of the research
analyst's household nor Rodman & Renshaw, LLC serves as an officer,
director or advisory board member of BioSante Pharmaceuticals.
Rodman & Renshaw, LLC does not make a market in BioSante
Pharmaceuticals' securities as of the date of this research report.
The above information is not intended to be used as a primary
basis of investment decisions. It is not a representation by Rodman &
Renshaw, LLC or an offer or the solicitation of an offer to buy any
security. Before investing in BioSante Pharmaceuticals, you should
carefully consider your risk tolerance and financial objectives.